Skip to main content
. 2024 Apr 10;14:183. doi: 10.1038/s41398-024-02854-7

Table 1.

Demographics, clinical measures, and data quality.

Groups (N = 122) P-value
HC (n = 52) FEP (n = 70)
Demographic variables
 Age (in years) 24.62 ± 6.28 24.03 ± 6.14 0.61
 Sex (M/F) 34/18 44/26 0.77
aParental occupation (SES) 4.46 ± 4.32 5.89 ± 4.71 0.33
Race
  White 32 21
  African American 11 43
  Asian 6 2
  Hispanic 1 2
  Pacific Islander 1 0
  Other 1 2
bNo. sf smokers (%) 8% 41%
  Smoking (Packs per day) 0.03 ± 0.09 0.24 ± 0.40 < 0.001
cNo. of cannabis users (%) 0% 30%
Clinical variables
 Diagnosis
  Schizophrenia 35
  Schizoaffective disorder 11
  Bipolar disorder with psychosis 3
  Schizophreniform disorder 4
  Psychosis NOS 13
  Brief psychotic disorder 2
  Major depressive disorder w/psychosis - 2
 Duration of untreated psychosis (in months) 21.43 ± 40.19
 BPRS
  Positive (4-items) 11.42 ± 3.38
  Negative 5.87 ± 3.21
  Total 50.16 ± 11.62
dRBANS
  Immediate memory 100.21 ± 16.21 81.90 ± 17.83 <0.001
  Visuospatial/Constructional 83.94 ± 13.51 75.00 ± 17.92 0.005
Language 98.15 ± 15.89 82.95 ± 16.87 < 0.001
  Attention 102.53 ± 16.01 80.45 ± 17.01 < 0.001
  Delayed memory 91.87 ± 8.86 77.32 ± 15.71 < 0.001
  Total index 93.38 ± 11.56 74.15 ± 15.89 < 0.001
Scan quality data
 MRS
  Cramer–Rao lower bands (Glx) 3.63 ± 0.65 4.37 ± 1.58 0.002
  Cramer–Rao lower bands (Cr) 0.80 ± 0.12 0.91 ± 0.19 0.001
  Cramer–Rao lower bands (Cho) 1.16 ± 0.23 1.29 ± 0.32 0.014
  Cramer–Rao lower bands (NAA) 0.72 ± 0.11 0.83 ± 0.17 < 0.001
  GM fraction 72.18 ± 7.13 72.08 ± 5.56 0.93
  WM fraction 12.86 ± 5.92 13.66 ± 6.04 0.47
  CSF fraction 14.19 ± 3.95 14.26 ± 3.69 0.92
eFC
  Mean motion (in mm) 0.15 ± 0.06 0.19 ± 0.09 0.01
  % of volumes after scrubbing 94.98 ± 5.59 91.10 ± 8.82 0.006

Mean ± standard deviation; data available for a118 subjects. Ranks determined from Diagnostic Interview for Genetic Studies where a higher rank (lower numerical value) corresponds to higher socioeconomic status (SES); b120 subjects; cmissing data for 8 patients; d109 subjects; e113 subjects; P-values are from χ2 and independent samples-t tests for differences between the groups.

RBANS repeatable battery for the assessment of neuropsychological status, BPRS brief psychiatric rating scale, MRS magnetic resonance spectroscopy, GM gray matter, WM white matter, CSF cerebrospinal fluid, FC functional connectivity.